SEC Company Response from Invivyd, (IVVD) — Oct 3, 2022
Invivyd, Inc.
Date: Oct. 3, 2022 · CIK: 0001832038 · Accession: 0001193125-22-256380
AI Filing Summary & Sentiment
File numbers found in text: 333-267643
Show Raw Text
CORRESP 1 filename1.htm CORRESP INVIVYD, INC. 1601 Trapelo Road, Suite 178 Waltham, MA 02451 October 3, 2022 VIA EDGAR Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Daniel Crawford Re: Invivyd, Inc. Registration Statement on Form S-3 Filed September 28, 2022 File No. 333-267643 Request for Acceleration of Effective Date Dear Mr. Crawford: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Invivyd, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on October 5, 2022, or as soon thereafter as possible. Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted. Very truly yours, INVIVYD, INC. By: /s/ Jill Andersen Name: Jill Andersen Title: Chief Legal Officer and Corporate Secretary